Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Myriad Genetics (MYGN) Debt Ratio (2016 - 2025)

Historic Debt Ratio for Myriad Genetics (MYGN) over the last 9 years, with Q3 2025 value amounting to 0.16.

  • Myriad Genetics' Debt Ratio rose 35504.93% to 0.16 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.16, marking a year-over-year increase of 35504.93%. This contributed to the annual value of 0.04 for FY2024, which is 1475.84% up from last year.
  • As of Q3 2025, Myriad Genetics' Debt Ratio stood at 0.16, which was up 35504.93% from 0.09 recorded in Q2 2025.
  • In the past 5 years, Myriad Genetics' Debt Ratio registered a high of 0.16 during Q3 2025, and its lowest value of 0.03 during Q2 2023.
  • In the last 4 years, Myriad Genetics' Debt Ratio had a median value of 0.04 in 2024 and averaged 0.06.
  • In the last 5 years, Myriad Genetics' Debt Ratio soared by 336742.44% in 2021 and then soared by 765.04% in 2024.
  • Quarter analysis of 4 years shows Myriad Genetics' Debt Ratio stood at 0.08 in 2021, then tumbled by 56.12% to 0.03 in 2023, then increased by 14.76% to 0.04 in 2024, then skyrocketed by 325.9% to 0.16 in 2025.
  • Its Debt Ratio was 0.16 in Q3 2025, compared to 0.09 in Q2 2025 and 0.06 in Q1 2025.